key: cord-0878402-nuhjata3
authors: Al‐Sabah, Salman; Al‐Haddad, Mohannad; Al‐Youha, Sarah; Jamal, Mohammad; Almazeedi, Sulaiman
title: COVID‐19: Impact of obesity and diabetes on disease severity
date: 2020-10-20
journal: Clin Obes
DOI: 10.1111/cob.12414
sha: dc95722ad9493b5d451121fb33847a898f1b6a42
doc_id: 878402
cord_uid: nuhjata3

The coronavirus disease 2019 (COVID‐19) pandemic is straining the healthcare system, particularly for patients with severe outcomes requiring admittance to the intensive care unit (ICU). This study investigated the potential associations of obesity and diabetes with COVID‐19 severe outcomes, assessed as ICU admittance. Medical history, demographic and patient characteristics of a retrospective cohort (1158 patients) hospitalized with COVID‐19 were analysed at a single centre in Kuwait. Univariate and multivariate analyses were performed to explore the associations between different variables and ICU admittance. Of 1158 hospitalized patients, 271 had diabetes, 236 had hypertension and 104 required admittance into the ICU. From patients with available measurements, 157 had body mass index (BMI) ≥25 kg/m(2). Univariate analysis showed that overweight, obesity class I and morbid obesity were associated with ICU admittance. Patients with diabetes were more likely to be admitted to the ICU. Two models for multivariate regression analysis assessed either BMI or diabetes on ICU outcomes. In the BMI model, class I and morbid obesities were associated with ICU admittance. In the diabetes model, diabetes was associated with increased ICU admittance, whereas hypertension had a protective effect on ICU admittance. In our cohort, overweight, obesity and diabetes in patients with COVID‐19 were associated with ICU admittance, increasing the risk of poor outcomes.

The outbreak and unprecedented spread of SARS-CoV-2, responsible for COVID-19, has taken the world by storm since December 2019.

On March 11, 2020 , the World Health Organization labelled the COVID-19 outbreak as a pandemic. 1 The novel coronavirus SARS-CoV-2 appears to affect certain individuals more severely than others. Most patients with SARS-CoV-2 infection have only mild or no symptoms; thus, they are considered to have a mild form of the disease. However, some patients have developed life-threatening acute respiratory distress syndrome, septic shock and multiorgan failure, including acute renal failure and cardiac injury caused by a cytokine storm, which increases the risk of mortality by 15% to 20%. 2 Various risk factors have been linked to the progression of COVID-19. Recognition of such factors can help to highlight a high-risk population and determine prevention strategies. Old age, chronic disease, respiratory disease, and cardiovascular disease have been studied intensively and found to have a significant association with the severity of COVID-19. 3 Patients with obesity and diabetes are also at risk of severe COVID-19 outcomes, which is particularly important to healthcare workers considering the high prevalence of these conditions in the Middle East, Europe, and the United States. 4, 5 Salman Al-Sabah and Mohannad Al-Haddad contributed equally In this study, we explored the potential association of obesity and diabetes with severe outcomes in patients hospitalized with SARS- patients with negative or equivocal results were excluded.

Demographic data, including age, sex, body mass index (BMI), fasting blood glucose level, systolic blood pressure, diastolic blood pressure and past medical history, were extracted from the Jaber Al-Ahmed Al-Sabah Hospital's electronic medical records. To maintain confidentiality, these data were de-identified.

The subjects were classified according to their BMI as follows:

normal weight (BMI of 18.5-24.9 kg/m 2 ), overweight (BMI of 25.0-29.9 kg/m 2 ) and obese (BMI ≥30 kg/m 2 ). The subjects with obesity were further stratified into classes: class I obesity was defined as a BMI of 30-34.9 kg/m 2 ; class II obesity, by a BMI of 35-39.9 kg/m 2 ; and morbid obesity, by a BMI ≥40 kg/m 2.6 Hypertension was defined as systolic blood pressure of ≥130 mmHg or diastolic blood pressure of ≥85 mmHg. 7 Prediabetes was defined as a fasting blood glucose level of 100 to 126 mg/dL, and diabetes was defined as a fasting blood glucose level of ≥126 mg/dL. 8 COVID-19 progression was defined as a patient's admission to the intensive care unit (ICU) for more active systemic treatment, such as systemic glucocorticoids or intravenous immunoglobulin, or for further advanced respiratory support, such as mechanical ventilation or extracorporeal membrane oxygenation.

Categorical variables were summarized as percentages and analysed with the chi-square test. Continuous variables were summarized as medians with interquartile ranges (IQRs) and compared in Student's t test or the nonparametric Mann-Whitney U test. Each promising variable with a plausible biological reason for inclusion in further analysis was verified for normal distribution using the Shapiro-Wilk and Kolmogorov-Smirnov tests. Continuous score variables were set to 0 or 1 to represent the values below or above a predefined threshold based on the literature; binary variables were also set at 0 or 1 (absent vs present, respectively).

Potential predictors for admission into the ICU were assessed using univariate and multivariate logistic regression analyses, and logistic regression models were adjusted for age and sex. Two multivariate models were constructed to consider the high association between obesity and diabetes. The associations between the exposure and outcomes were expressed in terms of the odds ratio (OR), along with 95% confidence intervals (CIs). Goodness-of-fit analyses of the models were performed using the C-statistic (area under the receiver operating characteristic [ROC] curve) and 95% CI. A 5% level was considered statistically significant for all the statistical tests. All statistical analyses were performed with R software (R Project for Statistical Computing, Vienna, Austria; R Core Team, 2019). were cough (n = 344, 29.7%), chills (n = 327, 28.2%) and sore throat (n = 135, 11.7%).

The baseline characteristics of the study patients are listed in 

The characteristics of patients admitted to ICU were compared with those who did not require ICU care ( those admitted into ICU was significantly higher than those who were not (16% vs 8.1%; P = .004).

All classifications of BMI that were higher than normal were associated with admission to the ICU (P-value = .006). The association between obesity, diabetes and hypertension was tested with the chisquare test, which revealed a relationship between obesity and diabetes (P-value <.001); we therefore decided to construct two predictive models for ICU progression.

Potential predictors for admission into ICU, including age, BMI and diabetes status, were analysed using univariate logistic regression (Table 3 ). Using BMI as the only predictor of ICU admission, the likelihood of admission was approximately 2.5-fold higher in patients who were overweight than in those with normal weight (OR = 2.45; 95% CI:

1.26-4.74; P = .008). Patients with obesity were 3.5 and 5.2 times more likely to be admitted to ICU than patients with normal weight, depending on whether they had class I or morbid obesity, respectively 

Considering the association between obesity and diabetes and excluding the potential confounding effect of these two variables on the outcome, we constructed two multivariate logistic regression models of prediction to accurately assess the associations of each condition with ICU admittance (Figure 1 ). In the first multivariate analysis model, where obesity was assessed, BMI (adjusted for age and sex) was significantly associated with ICU admittance. In patients who were overweight with class I or morbid obesities, the adjusted OR (AOR) were 1.91 (95% CI: In the second multivariate analysis model of prediction, diabetes (adjusted for age and sex) was associated with an increased the risk of ICU admittance (AOR = 5.49; 95% CI: 3.13-9.25, P≤.001); however, patients with pre-diabetes did not have an increased risk of ICU care (AOR: 1.4 [95% CI: 0.71-2.45]; Figure 1 ). Both multivariate models were validated by calculating the area under the ROC curve, which were > 0.800 for both multivariable models, indicating a good model discrimination (Figures 2 and 3 ).

This was the first retrospective cohort study in Kuwait and the Middle East which analysed the potential association of obesity and diabetes with COVID-19 disease severity. All patients in our cohort were admitted to a single centre, where they underwent standardized sets of investigations and received standardized treatment protocols. The exact mechanism underlying obesity and diabetes contributing to severe outcomes among patients with COVID-19 is still unclear.

However, one explanation could be related to the fact that expression of angiotensin-converting enzyme 2, the functional receptor for SARS-CoV, is up-regulated in patients with obesity and diabetes. 15 Furthermore, obesity and diabetes are linked with dysregulated lipid synthesis and clearance, which can initiate or aggravate pulmonary inflammation and injury. 16 Mechanistic studies on this matter are required to elucidate the mechanism by which diabetes and obesity contribute to disease severity and poor outcomes among patients with COVID-19.

The novel COVID-19 pandemic has created an unprecedented challenge in health care, exacerbating the unavailability of medical resources throughout the world. Bariatric surgeons have witnessed the rise of obesity and diabetes in epidemic proportion and have come to realize the effect of this rise on the medical care system. In our study, diabetes and BMI were associated with severe COVID-19 outcomes, as assessed by the ICU admittance of hospitalized patients. We acknowledge that our study had some limitations.

Given its retrospective nature, the unavailability of data as a result of omission or inadequate recording was a major limitation of this study. Another limitation of this study was the relatively higher ratio of male to female patients, which may limit the generalisability of the results to the population. Another factor that may impact the applicability of these findings to other populations, is the fact that obesity is quite different in the Middle East and Asia, compared to the Western part of the world, both from an epidemiological and physiological perspective. 17, 18 The relatively small size of our sample population was another limitation. Thus, larger, multicentre studies are required to confirm our findings, which will provide more robust scientific evidence. Nevertheless, our findings indicate that more patients with obesity and diabetes are likely to be admitted to the ICU as the pandemic continues. Hence, patients with COVID-19 with underlying obesity or diabetes must be categorized as a high-risk group.

Association of obesity with disease severity among patients with COVID-19. Obesity (Silver Spring, md)

COVID-19: consider cytokine storm syndromes and immunosuppression

Covid-19: risk factors for severe disease and death

The mutual effects of COVID-19 and obesity

Birdirectional relationship between COVID-19 and diabetes

Mean Body Mass Index (BMI). 2015. 7. Whelton PK

PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines

American Diabetes Association. 2. Classification and diagnosis of diabetes. Standards of medical care in diabetes-2019

Clinical infectious diseases: an official publication of the Infectious Diseases Society of America

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV

Obesity and mortality of COVID-19. Meta-analysis

Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis

Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumoniaa systematic review, meta-analysis, and meta-regression

The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity (Silver Spring, md)

Regulation of angiotensin converting enzyme 2 (ACE2) in obesity: implications for COVID-19. bio-Rxiv. 2020;046938

Outcomes in COVID-19: when an epidemic and pandemic collide

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

COVID-19: Impact of obesity and diabetes on disease severity

We would like to thank Dr Diana Marouco, PhD, for the editorial support provided. We would also like to thank Bruno Siegel Guerra for assistance with statistical analysis.

The authors have no conflict of interest to declare.

https://orcid.org/0000-0002-1918-321X